WebMar 26, 2024 · Ysios Capital raised €126M in October of 2016 for its second biotech fund, called Ysios BioFund II. The VC has had a great start in 2024 with three major acquisitions of companies in its portfolio: TiGenix for €520M, SAT-Dx for €153M and most recently Prexton Therapeutics for almost €1Bn. Ysios is based in Barcelona, and up and coming ... WebWe are a clinical stage biopharmaceutical research and development company with around 400 staff, including highly educated scientists and skilled technicians who share the same goal: To create safe and effective precision medicines targeting intractable cancers and autoimmune diseases, improving the standard of care for patients. ...
The Netherlands Biotechnology Companies - CrunchBase
WebApr 5, 2024 · The increasing numbers of treatment options in the clinic, and rapidly expanding numbers of new drugs in clinical development urge to implement novel technologies to identify the patients that benefit from it. VitroScans’ best-in-class technology is based on ex vivo 3D tumor testing using patients derived tumor tissue. WebProQR Therapeutics NV (NASDAQ: PRQR) is a Dutch biotechnology company based in Leiden, the Netherlands. The company was funded in 2012 by chief executive officer (CEO) Daniel de Boer. It specializes in the development of RNA therapeutics for rare genetic diseases with an ophthalmologic application. dewalt 18v cordless drill power tools
Ranking the Top 10 Biotech Clusters in Europe BioSpace
Web20Med Therapeutics is a Dutch biotechnology company focused on the development of prophylactic and therapeutic vaccines. Based on its proprietary bioresponsive polymer … Web2 days ago · Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. Our cell programming platform enables … WebFeb 28, 2024 · Rhythm Pharmaceuticals’ subsidiary Rhythm Pharmaceuticals Netherlands has purchased Dutch biotech company Xinvento and its portfolio of investigational therapeutics. Under the deal, Rhythm will acquire Xinvento’s 100% fully diluted equity for a $5m upfront payment and pay up to an additional $6m in preclinical development … dewalt 18v cordless drill review